This application describes a request for an ADAMHA Research Scientist Development Award for Dr. Charles P. France. The Department of Pharmacology at LSU Medical Center has a strong and growing research effort in ares of drug abuse and I will use the support provided by an RSDA to expand our overall drug abuse research program. Specifically, this request is an attempt to provide reliable salary support for me so that I can increase my research efforts in drug abuse, compete for additional extramural funds to support drug abuse research in my laboratory, and maintain an laboratory environment conducive to the training of young researchers in the behavioral pharmacology of drug abuse. My current formal teaching requirements as well as committee assignments will be reduced in the event this application is awarded. The primary areas of research supported by this application involve the use of drug discrimination procedures to study opioid dependence and withdrawal in nonhuman species. This research attempts to characterize important behavioral and pharmacological features of opioid dependence as well as identify novel compounds that might be effective in the treatment of opioid abuse. Moreover, receptor theory will be applied extensively to discrimination and other behavioral procedures both to test the utility of this approach and to characterize drug affinity, selectivity and efficacy in vivo. Other procedures that will be used in concert with drug discrimination procedures include analgesia studies in monkeys and mice, self-administration studies in rodents and monkeys, and studies in the electrically-stimulated mouse vas deferens. In addition, I will continue to pursue collaborative research on the immunologic effects of opioids in monkeys and in mice as well as studies on the importance of metabolic factors in the behavioral pharmacology of drugs of abuse. The RSDA will allow me to take advantage of the expertise of my current collaborators, particularly those with more molecular approaches. A continued and more extensive interaction with these scientists will increase my knowledge of various areas within pharmacology that are important to drug abuse in general.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Scientist Development Award - Research (K02)
Project #
5K02DA000211-05
Application #
2654337
Study Section
Special Emphasis Panel (SRCD)
Program Officer
Schnur, Paul
Project Start
1994-02-10
Project End
1999-01-31
Budget Start
1998-02-15
Budget End
1999-01-31
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Louisiana State University Hsc New Orleans
Department
Pharmacology
Type
Schools of Medicine
DUNS #
782627814
City
New Orleans
State
LA
Country
United States
Zip Code
70112
Boctor, Sherin Y; Martinez Jr, Joe L; Koek, Wouter et al. (2007) The cannabinoid CB1 receptor antagonist AM251 does not modify methamphetamine reinstatement of responding. Eur J Pharmacol 571:39-43
Williams, Jason M; Owens, W Anthony; Turner, Gregory H et al. (2007) Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol 5:e274
Owens, W Anthony; Sevak, Rajkumar J; Galici, Ruggero et al. (2005) Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. J Neurochem 94:1402-10
Galici, Ruggero; Galli, Aurelio; Jones, David J et al. (2003) Selective decreases in amphetamine self-administration and regulation of dopamine transporter function in diabetic rats. Neuroendocrinology 77:132-40
McMahon, L R; France, C P (2002) Acute and chronic effects of the neuroactive steroid pregnanolone on schedule-controlled responding in rhesus monkeys. Behav Pharmacol 13:545-55
Brandt, M R; Galici, R; France, C P (2000) The discriminative stimulus effects of morphine in pigeons responding under a progressive ratio schedule of food presentation. Behav Pharmacol 11:15-28
Winsauer, P J; Silvester, K R; Moerschbaecher, J M et al. (2000) Cocaine self-administration in monkeys: effects on the acquisition and performance of response sequences. Drug Alcohol Depend 59:51-61
Gauthier, C A; Bagley, J R; Brockunier, L L et al. (1999) Daily mirfentanil induces (cross-) tolerance to the rate-decreasing effects of morphine and not mirfentanil. Behav Pharmacol 10:543-7
France, C P; Gerak, L R (1994) Behavioral effects of 6-methylene naltrexone (nalmefene) in rhesus monkeys. J Pharmacol Exp Ther 270:992-9
Carr, D J; Baker, M L; Holmes, C et al. (1994) OHM3295: a fentanyl-related 4-heteroanilido piperidine with analgesic effects but not suppressive effects on splenic NK activity in mice. Int J Immunopharmacol 16:835-44